The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral Therapy
Abstract
BACKGROUND: Community-acquired respiratory viruses, such as influenza virus, are thought to be major causes of morbidity and mortality in patients who had undergone hematopoietic stem cell transplantation (HSCT). Risk factors for acquisition, progression to pneumonia, and the effect of antiviral therapy are unknown. METHODS: We reviewed records from patients with documented influenza over 12 consecutive respiratory-virus infection seasons at a single transplantation center. RESULTS: From 1 September 1989 through 31 March 2002, influenza virus was isolated from 62 of 4797 persons undergoing HSCT (1.3%); 44 patients had upper respiratory tract infections (URIs) alone, and 18 developed pneumonia. Among patients with influenza virus infection, pneumonia developed more commonly among those infected earlier after transplantation (median, 36 vs. 61 days, P=.04) and those with concurrent lymphopenia. Of the 51 cases that were initially diagnosed as URIs, 17 were treated with antivirals, and 34 were not treated. Six untreated patients (18%) developed pneumonia, whereas 1 (13%) of 8 patients treated with rimantadine and 0 of 9 treated with oseltamivir developed pneumonia. The duration of influenza virus shedding was longer in patients treated with steroid doses of >1 mg/kg than among those treated with doses of <1 mg/kg (mean, 15 vs. 9 days); there was a trend towards decreased shedding with oseltamivir therapy (but not rimantadine therapy) after controlling for steroid use (P<.08). The 30-day mortality rate was highest among patients who had progression to pneumonia (5 [28%] of 18 patients); pulmonary copathogens (such as Aspergillus fumigatus) were commonly isolated. CONCLUSIONS: Influenza virus infection is an important cause of mortality early after HSCT. Our nonrandomized data suggest that early antiviral therapy with neuraminidase inhibitors may prevent progression to pneumonia and decrease viral shedding, which may prevent both influenza-related death in index patients and nosocomial transmission to others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Self-citationHayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550
Clift, R., Buckner, C., Thomas, E., Bensinger, W., Bowden, R., Bryant, E., Deeg, H., Doney, K., Fisher, L., & Hansen, J. (1994) · Blood · doi:10.1182/blood.v84.6.2036.2036 · Cited by 358
Cooper, N. J., Sutton, A. J., Abrams, K. R., Wailoo, A., Turner, D., & Nicholson, K. G. (2003) · BMJ · doi:10.1136/bmj.326.7401.1235 · Cited by 357
Nichols, W. G., Corey, L., Gooley, T., Davis, C., & Boeckh, M. (2001) · Blood · doi:10.1182/blood.v98.3.573 · Cited by 290
Self-citationLjungman, P., Ward, K., Crooks, B., Parker, A., Martino, R., Shaw, P., Brinch, L., Brune, M., De La Camara, R., Dekker, A., et al. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703139 · Cited by 289
Prolonged Shedding of Multidrug-Resistant Influenza A Virus in an Immunocompromised Patient
Weinstock, D. M., Gubareva, L. V., & Zuccotti, G. (2003) · New England Journal of Medicine · doi:10.1056/nejm200302273480923 · Cited by 207
Bowden, M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00007-7 · Cited by 200
Influenza A virus infections among hospitalized adult bone marrow transplant recipients.
Whimbey, E. E., Elting, L. S., Couch, R. B., et al. (1994) · PubMed · Cited by 191
Viral infections in immunocompromised patients: whatʼs new with respiratory viruses?
Ison, M. G., & Hayden, F. G. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200208000-00002 · Cited by 178
Prevention and control of influenza
Cox, N. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90373-2 · Cited by 176
Englund, J. A., Champlin, R. E., Wyde, P. R., Kantarjian, H., Atmar, R. L., Tarrand, J., Yousuf, H., Regnery, H., Klimov, A. I., Cox, N. J., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/516358 · Cited by 162
Rl, S. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82652-7 · Cited by 159
Influenza A in Immunocompromised Patients
Ljungman, P. T., Andersson, J., ASCHAN, J., Barkholt, L., Ehrnst, A., Johansson, M., & Weiland, O. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.2.244 · Cited by 126
Deeg, H. J., Lin, D. Y., Leisenring, W. M., Boeckh, M., Anasetti, C., Appelbaum, F. R., Chauncey, T. R., Doney, K., Flowers, M. E. D., Martin, P. J., et al. (1997) · Blood · doi:10.1182/blood.v89.10.3880 · Cited by 123
Self-citationSafety and Efficacy of Nebulized Zanamivir in Hospitalized Patients with Serious Influenza
NIAID Collaborative Antiviral Study Group, Ison, M. G., Gnann, J. W., Nagy-Agren, S. E., Treanor, J. J., Payá, C. V., Steigbigel, R. T., Elliott, M. J., Weiss, H. L., & Hayden, F. G. (2003) · Antiviral Therapy · doi:10.1177/135965350300800301 · Cited by 118
Balow, J. E., Hurley, D. L., & Fauci, A. S. (1975) · The Journal of Immunology · doi:10.4049/jimmunol.114.3.1072 · Cited by 86
Armitage, J. O., & Bishop, M. R. (1996) · Springer eBooks · doi:10.1007/978-94-009-0165-0_1 · Cited by 63
The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation
Johny, A., Clark, A., Price, N., Carrington, D., Oakhill, A., & Marks, D. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703343 · Cited by 56
Storb, R. F., Leisenring, W. M., Deeg, H. J., Anasetti, C., Appelbaum, F. R., Bensinger, W., Buckner, C. D., Clift, R. A., Doney, K., & Hansen, J. A. (1994) · Blood · doi:10.1182/blood.v83.9.2749.2749 · Cited by 46
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Buckner, C. D., Ra, C., Fr, A., et al. (1991) · PubMed · Cited by 26
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Self-citationTomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Self-citationUyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy866 · Cited by 795
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 704
Self-citationMuthuri, S. G., Venkatesan, S., Myles, P. R., Leonardi-Bee, J., Al Khuwaitir, T. S. A., Al Mamun, A., Anovadiya, A. P., Azziz-Baumgartner, E., Báez, C., Bassetti, M., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70041-4 · Cited by 644
Metadata
- Authors
- Nichols, W. G., Guthrie, K. A., Corey, L., & Boeckh, M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-11-01
- Volume
- 39
- Issue
- 9
- Pages
- 1300-1306
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171016583
- Cited by
- 377
- References
- 23
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.